Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us

Category: upfront

J&J pays $2.2B upfront for Ollin, taps Blackstone to fund eye disease trial
Research and Discoveryupfront

J&J pays $2.2B upfront for Ollin, taps Blackstone to fund eye disease trial

Johnson & Johnson is buying ophthalmology biotech Ollin Biosciences and its late-stage bispecific antibody for $2.2 billion upfront. The acquisition…

byadminNovember 16, 2026

| Depth News by Ascendoor | Powered by WordPress.